Analyst Consensus ?
ConsensusBuy45 ratings
Bullish3373.3%
Neutral1226.7%
Bearish00.0%
FN2 Earnings Intelligence
AutoZone, Inc. complete analyst coverage
AutoZone, Inc. (AZO) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$2,855.31Previous close
$1,490Low
$3,450.86Average
$4,800High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Oppenheimer | Outperform | Outperform | Maintain | Sep 18, 2026 |
| Citigroup | Buy | Buy | Maintain | Sep 14, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 10, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 31, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 4, 2026 |
| Truist Securities | Buy | Buy | Maintain | May 27, 2026 |
| Roth Capital | Buy | Buy | Maintain | May 27, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | May 27, 2026 |
| Mizuho | Neutral | Neutral | Maintain | May 27, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 27, 2026 |
| Guggenheim | Buy | Buy | Maintain | May 27, 2026 |
| DA Davidson | Buy | Buy | Maintain | May 27, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | May 27, 2026 |
| Baird | Neutral | Neutral | Maintain | May 27, 2026 |
| Argus Research | Buy | Hold | Upgrade | Mar 9, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Mar 4, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 16, 2025 |
| UBS | Buy | Buy | Maintain | Dec 10, 2025 |
| Goldman Sachs | Buy | Neutral | Upgrade | Nov 13, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Sep 24, 2025 |
| B of A Securities | Buy | Neutral | Upgrade | May 21, 2025 |
| Wedbush | Outperform | Outperform | Maintain | Mar 5, 2025 |
| Roth MKM | Buy | Buy | Maintain | Mar 5, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Dec 6, 2023 |
| Jefferies | Buy | Buy | Maintain | Sep 20, 2022 |
| MKM Partners | Buy | Buy | Maintain | Jun 23, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Sep 22, 2021 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 26, 2021 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Sep 8, 2020 |
| Nomura Instinet | Buy | Buy | Maintain | May 27, 2020 |
| Nomura | Buy | Buy | Maintain | May 27, 2020 |
| CFRA | Buy | Strong Buy | Downgrade | May 26, 2020 |
| Citi | Buy | Buy | Maintain | Sep 13, 2019 |
| Deutsche Bank | Buy | Buy | Maintain | Feb 27, 2019 |
| Argus | Buy | Buy | Maintain | Dec 6, 2018 |
| Bank of America | Neutral | Buy | Downgrade | Sep 17, 2018 |
| Moffett Nathanson | Neutral | Neutral | Maintain | Dec 4, 2017 |
| Susquehanna | Neutral | Neutral | Maintain | Aug 25, 2016 |
| BTIG Research | Buy | Buy | Maintain | Jun 1, 2016 |
| Gabelli & Co. | Buy | Buy | Maintain | Apr 15, 2016 |
| Sterne Agee | Neutral | Underperform | Upgrade | Mar 4, 2015 |
| William Blair | Perform | Market Perform | Maintain | Sep 30, 2014 |
| Argus Capital | Hold | Buy | Downgrade | Sep 25, 2014 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Jul 18, 2014 |
| Stifel | Hold | Buy | Downgrade | Jul 18, 2014 |
Named analyst price targets
Upside is calculated against the persisted previous close $2,855.31. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Analyst unavailable | $3,500 | $2,832.92 | +22.6% | Sep 18, 2026 |
| Wells Fargo | Zachary Fadem | $3,500 | $2,910.97 | +22.6% | Sep 10, 2026 |
| Piper Sandler | Analyst unavailable | $3,500 | $2,977.82 | +22.6% | Aug 31, 2026 |
| Barclays | Seth Sigman | $3,637 | $2,990.27 | +27.4% | Aug 4, 2026 |
| Truist Financial | Scot Ciccarelli | $3,817 | $3,058.79 | +33.7% | May 27, 2026 |
| Truist Financial | Analyst unavailable | $3,700 | $3,068.6 | +29.6% | May 27, 2026 |
| D.A. Davidson | Michael Baker | $3,750 | $2,999.47 | +31.3% | May 27, 2026 |
| Roth Capital | Analyst unavailable | $4,023 | $3,100.11 | +40.9% | May 27, 2026 |
| Morgan Stanley | Analyst unavailable | $3,605 | $3,100.11 | +26.3% | May 27, 2026 |
| Guggenheim | Analyst unavailable | $4,000 | $3,100.11 | +40.1% | May 27, 2026 |
| BMO Capital | Analyst unavailable | $4,000 | $3,100.11 | +40.1% | May 27, 2026 |
| Mizuho Securities | Analyst unavailable | $3,200 | $3,100.11 | +12.1% | May 27, 2026 |
| Robert W. Baird | Analyst unavailable | $3,600 | $3,100.11 | +26.1% | May 27, 2026 |
| Argus Research | Analyst unavailable | $4,325 | $3,672.68 | +51.5% | Mar 9, 2026 |
| D.A. Davidson | Michael Baker | $4,300 | $3,742.02 | +50.6% | Mar 5, 2026 |
| Mizuho Securities | David Bellinger | $3,600 | $3,694.41 | +26.1% | Mar 5, 2026 |
| Truist Financial | Scot Ciccarelli | $4,045 | $3,663.82 | +41.7% | Mar 4, 2026 |
| UBS | Analyst unavailable | $4,800 | $3,637.17 | +68.1% | Mar 3, 2026 |
| D.A. Davidson | Michael Baker | $4,100 | $3,675.79 | +43.6% | Mar 3, 2026 |
| Robert W. Baird | Analyst unavailable | $3,900 | $3,681.26 | +36.6% | Feb 9, 2026 |
| UBS | Michael Lasser | $4,555 | $3,763.27 | +59.5% | Feb 4, 2026 |
| Morgan Stanley | Simeon Gutman | $4,000 | $3,472.66 | +40.1% | Jan 15, 2026 |
| Barclays | Analyst unavailable | $3,880 | $3,318.08 | +35.9% | Jan 8, 2026 |
| Mizuho Securities | David Bellinger | $3,550 | $3,303.82 | +24.3% | Jan 5, 2026 |
| Truist Financial | Scot Ciccarelli | $4,076 | $3,415.43 | +42.8% | Dec 10, 2025 |
| Jefferies | Bret Jordan | $4,400 | $3,428.95 | +54.1% | Dec 10, 2025 |
| Roth Capital | Scott Stember | $4,650 | $3,390 | +62.9% | Dec 10, 2025 |
| D.A. Davidson | Michael Baker | $4,500 | $3,405.34 | +57.6% | Dec 10, 2025 |
| Mizuho Securities | Analyst unavailable | $3,850 | $3,394.07 | +34.8% | Dec 10, 2025 |
| Guggenheim | Analyst unavailable | $4,400 | $3,493.36 | +54.1% | Dec 10, 2025 |
| BMO Capital | Analyst unavailable | $4,400 | $3,493.36 | +54.1% | Dec 10, 2025 |
| UBS | Analyst unavailable | $4,325 | $3,493.36 | +51.5% | Dec 10, 2025 |
| Wells Fargo | Zachary Fadem | $4,500 | $3,493.36 | +57.6% | Dec 10, 2025 |
| Barclays | Analyst unavailable | $4,318 | $3,493.36 | +51.2% | Dec 10, 2025 |
| Evercore ISI | Greg Melich | $4,100 | $3,493.36 | +43.6% | Dec 10, 2025 |
| Robert W. Baird | Justin Kleber | $4,500 | $3,822.92 | +57.6% | Dec 3, 2025 |
| D.A. Davidson | Michael Baker | $4,850 | $3,680.24 | +69.9% | Nov 6, 2025 |
| BMO Capital | Tristan Thomas-Martin | $4,600 | $4,147.26 | +61.1% | Sep 25, 2025 |
| Raymond James | Bobby Griffin | $4,800 | $4,090.48 | +68.1% | Sep 24, 2025 |
| Morgan Stanley | Simeon Gutman | $4,700 | $4,099.32 | +64.6% | Sep 24, 2025 |
| Wells Fargo | Zachary Fadem | $4,700 | $4,120 | +64.6% | Sep 24, 2025 |
| Evercore ISI | Greg Melich | $4,500 | $4,166.32 | +57.6% | Sep 18, 2025 |
| Wolfe Research | Analyst unavailable | $4,741 | $4,232.57 | +66.0% | Sep 17, 2025 |
| Truist Financial | Analyst unavailable | $4,504 | $4,232.57 | +57.7% | Sep 17, 2025 |
| Roth Capital | Scott Stember | $4,135 | $3,749.81 | +44.8% | Jun 2, 2025 |
| D.A. Davidson | Michael Baker | $4,192 | $3,829.93 | +46.8% | May 23, 2025 |
| Evercore ISI | Greg Melich | $3,950 | $3,879.97 | +38.3% | May 19, 2025 |
| BMO Capital | Analyst unavailable | $3,850 | $3,555.88 | +34.8% | Mar 5, 2025 |
| D.A. Davidson | Analyst unavailable | $3,500 | $3,555.88 | +22.6% | Mar 5, 2025 |
| Guggenheim | Analyst unavailable | $3,850 | $3,555.88 | +34.8% | Mar 5, 2025 |
| Roth Capital | Analyst unavailable | $3,763 | $3,555.88 | +31.8% | Mar 5, 2025 |
| Raymond James | Analyst unavailable | $4,000 | $3,555.88 | +40.1% | Mar 5, 2025 |
| Wells Fargo | Analyst unavailable | $3,850 | $3,555.88 | +34.8% | Mar 5, 2025 |
| UBS | Analyst unavailable | $4,025 | $3,555.88 | +41.0% | Mar 5, 2025 |
| Argus Research | Bill Selesky | $3,678 | $3,250 | +28.8% | Jan 2, 2025 |
| BMO Capital | Tristan Thomas-Martin | $3,700 | $3,370.27 | +29.6% | Dec 13, 2024 |
| Evercore ISI | Greg Melich | $3,450 | $3,342.72 | +20.8% | Dec 11, 2024 |
| Truist Financial | Scot Ciccarelli | $3,753 | $3,342.72 | +31.4% | Dec 11, 2024 |
| UBS | Michael Lasser | $3,875 | $3,342.72 | +35.7% | Dec 11, 2024 |
| Wells Fargo | Zachary Fadem | $3,750 | $3,342.72 | +31.3% | Dec 11, 2024 |
| Evercore ISI | Greg Melich | $3,390 | $3,337.23 | +18.7% | Dec 9, 2024 |
| Roth Capital | Scott Stember | $3,634 | $3,100 | +27.3% | Oct 16, 2024 |
| Goldman Sachs | Kate McShane | $2,917 | $3,129.78 | +2.2% | Oct 14, 2024 |
| Argus Research | Bill Selesky | $3,560 | $3,189.33 | +24.7% | Sep 27, 2024 |
| Truist Financial | Scot Ciccarelli | $3,341 | $3,051.15 | +17.0% | Sep 25, 2024 |
| Mizuho Securities | David Bellinger | $3,350 | $3,043.97 | +17.3% | Sep 25, 2024 |
| Citigroup | Steven Zaccone | $3,500 | $3,043.97 | +22.6% | Sep 25, 2024 |
| CFRA | Garrett Nelson | $3,300 | $3,036.18 | +15.6% | Sep 24, 2024 |
| Oppenheimer | Brain Nagel | $2,600 | $3,031.42 | -8.9% | Sep 20, 2024 |
| Evercore ISI | Greg Melich | $3,350 | $3,040.09 | +17.3% | Sep 20, 2024 |
| Barclays | Matthew McClintock | $3,024 | $3,123.36 | +5.9% | Sep 16, 2024 |
| Evercore ISI | Greg Melich | $3,278 | $2,940.11 | +14.8% | Jun 27, 2024 |
| Cowen & Co. | Max Rakhlenko | $3,450 | $2,763.55 | +20.8% | Jun 6, 2024 |
| Truist Financial | Scot Ciccarelli | $3,394 | $2,800.01 | +18.9% | May 22, 2024 |
| UBS | Michael Lasser | $3,340 | $2,820.83 | +17.0% | May 22, 2024 |
| Morgan Stanley | Simeon Gutman | $3,038 | $2,820.83 | +6.4% | May 22, 2024 |
| Wolfe Research | Chris Bottiglieri | $3,000 | $2,820.83 | +5.1% | May 22, 2024 |
| Evercore ISI | Greg Melich | $3,250 | $2,820.83 | +13.8% | May 22, 2024 |
| CFRA | Garrett Nelson | $3,250 | $2,834.66 | +13.8% | May 21, 2024 |
| Goldman Sachs | Kate McShane | $3,000 | $2,677.85 | +5.1% | Dec 5, 2023 |
| Truist Financial | Scot Ciccarelli | $2,933 | $2,618.57 | +2.7% | Dec 1, 2023 |
| Morgan Stanley | Simeon Gutman | $2,750 | $2,577.02 | -3.7% | Sep 20, 2023 |
| D.A. Davidson | Michael Baker | $2,340 | $2,535.29 | -18.0% | Sep 18, 2023 |
| UBS | Michael Lasser | $2,900 | $2,493.83 | +1.6% | Jun 16, 2023 |
| Evercore ISI | Greg Melich | $2,700 | $2,399.11 | -5.4% | Jun 12, 2023 |
| Barclays | Analyst unavailable | $2,663 | $2,419.81 | -6.7% | Feb 8, 2023 |
| Raymond James | Bobby Griffin | $2,600 | $2,465.89 | -8.9% | Dec 7, 2022 |
| Truist Financial | Analyst unavailable | $2,800 | $2,482.04 | -1.9% | Dec 7, 2022 |
| UBS | Analyst unavailable | $2,540 | $2,449.79 | -11.0% | Dec 7, 2022 |
| Wells Fargo | Analyst unavailable | $2,850 | $2,545.98 | -0.2% | Nov 29, 2022 |
| Stephens | Daniel Imbro | $2,400 | $2,243.65 | -15.9% | Oct 5, 2022 |
| Argus Research | Analyst unavailable | $2,330 | $2,111.42 | -18.4% | Sep 27, 2022 |
| Truist Financial | Analyst unavailable | $2,292 | $2,117.34 | -19.7% | Sep 20, 2022 |
| J.P. Morgan | Christopher Horvers | $2,450 | $2,097.59 | -14.2% | Sep 20, 2022 |
| Jefferies | Analyst unavailable | $2,450 | $2,114.68 | -14.2% | Sep 20, 2022 |
| J.P. Morgan | Analyst unavailable | $2,660 | $2,114.68 | -6.8% | Sep 20, 2022 |
| Wedbush | Analyst unavailable | $2,350 | $2,101.21 | -17.7% | Sep 20, 2022 |
| Citigroup | Analyst unavailable | $2,520 | $2,114 | -11.7% | Sep 20, 2022 |
| UBS | Analyst unavailable | $2,260 | $2,216.56 | -20.8% | Sep 12, 2022 |
| Wells Fargo | Analyst unavailable | $2,450 | $2,198.74 | -14.2% | Sep 9, 2022 |
| Raymond James | Analyst unavailable | $2,350 | $2,224.32 | -17.7% | Jul 20, 2022 |
| MKM Partners | David Bellinger | $2,350 | $2,159.81 | -17.7% | Jul 2, 2022 |
| Goldman Sachs | Kate McShane | $2,296 | $2,159.81 | -19.6% | Jul 2, 2022 |
| Goldman Sachs | Kate McShane | $2,296 | $2,169.27 | -19.6% | Jun 28, 2022 |
| Morgan Stanley | Simeon Gutman | $2,420 | $2,013.81 | -15.2% | Jun 16, 2022 |
| Stephens | Analyst unavailable | $2,285 | $1,964.66 | -20.0% | May 26, 2022 |
| Truist Financial | Scot Ciccarelli | $2,174 | $1,928.31 | -23.9% | May 25, 2022 |
| D.A. Davidson | Analyst unavailable | $1,920 | $1,938.13 | -32.8% | May 25, 2022 |
| Raymond James | Analyst unavailable | $2,400 | $2,175.95 | -15.9% | Apr 19, 2022 |
| Citigroup | Steven Zaccone | $2,210 | $1,878.77 | -22.6% | Mar 2, 2022 |
| UBS | Michael Lasser | $2,100 | $1,951.16 | -26.5% | Jan 28, 2022 |
| D.A. Davidson | Michael Baker | $2,100 | $2,084.52 | -26.5% | Dec 30, 2021 |
| Oppenheimer | Brian Nagel | $2,500 | $1,965.83 | -12.4% | Dec 9, 2021 |
| Wedbush | Seth Basham | $2,250 | $1,988.86 | -21.2% | Dec 8, 2021 |
| Goldman Sachs | Kate McShane | $2,045 | $1,988.86 | -28.4% | Dec 8, 2021 |
| Stephens | Daniel Imbro | $2,210 | $1,988.86 | -22.6% | Dec 8, 2021 |
| CFRA | Garrett Nelson | $1,925 | $1,911.84 | -32.6% | Nov 15, 2021 |
| Bank of America Securities | Elizabeth Lane Suzuki | $1,490 | $1,683.76 | -47.8% | Sep 22, 2021 |
| Credit Suisse | Lavesh Hemnani | $1,785 | $1,683.76 | -37.5% | Sep 22, 2021 |
Track every rating change on AZO the moment it posts. Free to start.
Start freeGet the AZO recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.